Reducing the Out-of-Pocket Costs of Disease-Modifying Therapies for Medicare Beneficiaries With Multiple Sclerosis
{{output}}
Background and objectives: The Inflation Reduction Act (IRA) introduced major reforms to Medicare Part D, including an annual out-of-pocket (OOP) maximum and the Medicare Prescription Payment Plan (MPPP), which allows beneficiari... ...
